TJX Companies

TJX shares have rebounded more than 13% from a mid-September low but remain about 8% below their post-earnings level after Marmaxx reported a slowdown in comparable sales to 1%. Morgan Stanley's consumer survey indicates the weakness was driven largely by cuts to overall spending and price sensitivity rather than structural problems with TJX's assortment, and brand perception remains top among off-price peers. Analysts expect any sales inflection unlikely in Q3 and look to Q4 at the earliest, while investors view the off-price model as resilient and are using ongoing weakness as buying opportunities. » More on cnbc.com

TJX Companies reported Q2 fiscal 2027 sales of $15.18 billion, consolidated comparable sales up 4% and adjusted EPS up 11%, and raised its full-year EPS outlook. Weakness was concentrated in Marmaxx (TJ Maxx, Marshalls, Sierra), where comparable sales rose just 1% as management cited store‑mix execution issues it says are fixed but did not disclose specifics. Jim Cramer expressed concern over the unexplained stumble after Ross posted much stronger comp growth, warning the Marmaxx slowdown could persist and weigh on TJX stock if recovery takes longer than management expects. » More on finance.yahoo.com

TJX stock reached a new 52-week low of $125.49, 26% below the year high of $170; it is down 9.66% over the past year and nearly 17% year-to-date. Technical indicators point to oversold conditions, and an InvestingPro fair-value calculation signals possible undervaluation. Operationally, TJX reported better-than-expected Q2 results (adjusted EPS $1.22, revenue $15.2bn, comparable-store sales +4%, adjusted pre-tax profit margin 11.9%), while concerns remain about a slowdown in the Marmaxx segment. Analyst reactions ranged from downgrades and price-target cuts to confirmations and raises, reflecting a mixed assessment of the company's prospects. » More on de.investing.com